Literature DB >> 15921708

Postsynaptic actions of substance P on rat periaqueductal grey neurons in vitro.

Geoffrey M Drew1, Vanessa A Mitchell, Christopher W Vaughan.   

Abstract

The postsynaptic actions of substance P on rat midbrain periaqueductal grey (PAG) neurons were examined using whole-cell patch-clamp recordings in brain slices. Substance P produced an inward current in a subpopulation (60%) of PAG neurons. The substance P induced current was concentration dependent (EC50=27 nM) and was reduced by the NK1, NK2 and NK3 antagonists L-732,138 (20 microM), GR 159897 (3 microM) and SB 218795 (3 microM). The selective NK1, NK2 and NK3 agonists [Sar9,Met(O2)11]-Substance P (100 nM), GR 64349 (300-500 nM) and senktide (300 nM) also produced inward currents in subpopulations of neurons. A greater proportion of substance P-sensitive neurons (70%) than substance P-insensitive neurons (31%) responded to the mu/delta opioid agonist met-enkephalin (10 microM). Substance P reduced the outward current produced by met-enkephalin. The reversal potential of the substance P induced current varied from -5 mV to below -140 mV in the absence of met-enkephalin, and was -105 mV in the presence of met-enkephalin. These results indicate that substance P acts via NK1, NK2 and NK3 receptors to excite subpopulations of opioid-sensitive and insensitive PAG neurons by increasing a non-selective cation conductance and by reducing a K+ current. In addition, substance P has anti-opioid actions that are largely mediated by a reduction in the opioid induced K+ current.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921708     DOI: 10.1016/j.neuropharm.2005.04.011

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  13 in total

1.  Evidence for mediation of nociception by injection of the NK-3 receptor agonist, senktide, into the dorsal periaqueductal gray of rats.

Authors:  Gabriel S Bassi; Ana C Broiz; Margarete Z Gomes; Marcus L Brandão
Journal:  Psychopharmacology (Berl)       Date:  2008-12-18       Impact factor: 4.530

2.  Modulation of lymphatic muscle contractility by the neuropeptide substance P.

Authors:  Michael J Davis; Megan M Lane; Ann M Davis; David Durtschi; David C Zawieja; Mariappan Muthuchamy; Anatoliy A Gashev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-06       Impact factor: 4.733

Review 3.  Neuroplasticity of ascending and descending pathways after somatosensory system injury: reviewing knowledge to identify neuropathic pain therapeutic targets.

Authors:  P Boadas-Vaello; S Castany; J Homs; B Álvarez-Pérez; M Deulofeu; E Verdú
Journal:  Spinal Cord       Date:  2016-01-12       Impact factor: 2.772

Review 4.  Cannabinoids in the descending pain modulatory circuit: Role in inflammation.

Authors:  Courtney A Bouchet; Susan L Ingram
Journal:  Pharmacol Ther       Date:  2020-01-29       Impact factor: 12.310

5.  Control of enteric neuromuscular functions by purinergic A(3) receptors in normal rat distal colon and experimental bowel inflammation.

Authors:  L Antonioli; M Fornai; R Colucci; N Ghisu; M Tuccori; O Awwad; A Bin; C Zoppellaro; I Castagliuolo; R M Gaion; M C Giron; C Blandizzi
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

6.  Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray.

Authors:  Vanessa A Mitchell; Hyo-Jin Jeong; Geoffrey M Drew; Christopher W Vaughan
Journal:  Neuropsychopharmacology       Date:  2011-04-27       Impact factor: 7.853

7.  Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway.

Authors:  Geoffrey M Drew; Benjamin K Lau; Christopher W Vaughan
Journal:  J Neurosci       Date:  2009-06-03       Impact factor: 6.167

8.  Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey.

Authors:  V A Mitchell; H Kawahara; C W Vaughan
Journal:  J Physiol       Date:  2009-04-09       Impact factor: 5.182

9.  An NK1 receptor antagonist microinjected into the periaqueductal gray blocks lateral hypothalamic-induced antinociception in rats.

Authors:  Janean E Holden; Julie A Pizzi; Younhee Jeong
Journal:  Neurosci Lett       Date:  2009-02-07       Impact factor: 3.046

10.  Substance P excites GABAergic neurons in the mouse central amygdala through neurokinin 1 receptor activation.

Authors:  L Sosulina; C Strippel; H Romo-Parra; A L Walter; T Kanyshkova; S B Sartori; M D Lange; N Singewald; H-C Pape
Journal:  J Neurophysiol       Date:  2015-09-02       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.